• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Thorac Dis . Epidemiological features and risk factors of SARS-CoV-2 reinfection: a retrospective cohort analysis in Xiamen, China

tetano

Editor, Senior Moderator
J Thorac Dis


. 2025 Jul 31;17(7):4732-4745.
doi: 10.21037/jtd-24-1703. Epub 2025 Jul 28. Epidemiological features and risk factors of SARS-CoV-2 reinfection: a retrospective cohort analysis in Xiamen, China

Yunkang Zhao[SUP] #[/SUP][SUP] 1 [/SUP], Yao Wang[SUP] #[/SUP][SUP] 1 [/SUP], Yidun Zhang[SUP] #[/SUP][SUP] 2 [/SUP], Zeyu Zhao[SUP] 1 [/SUP], Buasiyamu Abudunaibi[SUP] 1 [/SUP], Kang Fang[SUP] 1 [/SUP], Huimin Qu[SUP] 1 [/SUP], Qiao Liu[SUP] 1 [/SUP], Yanhua Su[SUP] 1 [/SUP], Chenghao Su[SUP] 2 3 [/SUP], Zhinan Guo[SUP] 2 [/SUP], Tianmu Chen[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Recently, surges in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections in China have raised public concern. We investigated the epidemiological features and risk factors for SARS-CoV-2 reinfection in China.
Methods: A retrospective cohort study was conducted in Xiamen, China (2021-2023) with two subcohorts: Delta-Omicron (cohort 1) and Omicron-Omicron (cohort 2). Descriptive analysis and ensemble modeling were employed to evaluate reinfections.
Results: A total of 327 cases without fatalities were included. Reinfections accounted for 14.68% of cases, with 22.51% in cohort 1 and 3.68% in cohort 2. Compared with primary infections (PIs) (99.69% symptomatic, 56.54% hospitalized), reinfections were less severe, with fewer symptomatic instances (47.92%) and hospitalizations (4.65%). The majority of reinfections (83.33%) occurred following the relaxation of strict public health and social measures. The median time interval between PI and reinfection was longer for cohort 1 (462 days) than for cohort 2 (280 days). Reinfection risks were noted among lesser developed regions, those without persistent PI, those with primary Delta variant infection, government and hospital workers, and unvaccinated individuals.
Conclusions: SARS-CoV-2 reinfections are generally less severe and are influenced by the relaxation of control measures, viral evolution, and changing patterns of population immunity and contact; this underscores the need for ongoing surveillance and targeted public health strategies to manage future infection waves.

Keywords: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); coronavirus disease 2019 (COVID-19); primary infection (PI); reinfection.

 
Back
Top Bottom